Login Register Cart 0
Generic placeholder image

Recent Patents on Biotechnology

Editor-in-Chief

ISSN (Print): 1872-2083
ISSN (Online): 2212-4012

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Development of Moloney Murine Leukemia Virus Reverse Transcriptase Fused with Archaeal DNA-binding Protein Sis7a

Author(s): Goldyna M. Simanjuntak, Azzania Fibriani*, Amalia A. Fananda and Nicholas Yamahoki

Volume 18, Issue 1, 2024

Published on: 27 April, 2023

Page: [71 - 83] Pages: 13

DOI: 10.2174/1872208317666230403104302

Price: $65

Abstract

Introduction: Moloney Murine Leukemia Virus Reverse Transcriptase (MMLV RT) is a common enzyme used to convert RNA sequences into cDNA. However, it still has its shortcomings, especially in terms of processivity and thermostability. According to a previous patent, the fusion of polymerase enzyme to an archaeal DNA-binding protein has been proven to enhance its performance. Furthermore, recent studies have also stated that the fusion of a polymerase enzyme to an archaeal DNA-binding protein is predicted to improve its thermostability and processivity.

Aim: As an early stage of enzyme development, this study aimed to design, express, and purify enzymatically active MMLV RT fused with archaeal DNA-binding protein.

Methods: RT fusion proteins were designed and evaluated using in silico methods. The RT fusion enzyme was then expressed in Escherichia coli BL21(DE3) and purified. Its reverse transcriptional activity was proved using reverse transcription quantitative polymerase chain reaction (RT-qPCR).

Results: This study showed that MMLV RT fusion with Sis7a protein at its C-terminal end using commercial linker (GGVDMI) produced the best in silico evaluation results. The RT fusion was successfully expressed and purified. It was also known that the optimal condition for expression of the RT fusion was using 0.5 mM IPTG with post-induction incubation at room temperature (± 26°C) for 16 hours. In addition, the activity assay proved that the RT fusion has the reverse transcriptional activity.

Conclusion: This study shows that the designed MMLV RT Sis7a fusion can be expressed and purified, is enzymatically active, and has the potential to be developed as an improved RT enzyme. Further study is still needed to prove its thermostability and processivity, and further characterize, and plan production scale-up of the MMLV RT Sis7a fusion for commercial use.

« Previous Next »
Graphical Abstract

[1]
Coffin JM, Fan H. The discovery of reverse transcriptase. Annu Rev Virol 2016; 3(1): 29-51.
[http://dx.doi.org/10.1146/annurev-virology-110615-035556] [PMID: 27482900]
[2]
Baranauskas A, Paliksa S, Alzbutas G, et al. Generation and characterization of new highly thermostable and processive M-MuLV reverse transcriptase variants. Protein Eng Des Sel 2012; 25(10): 657-68.
[http://dx.doi.org/10.1093/protein/gzs034] [PMID: 22691702]
[3]
DeStefano JJ, Buiser RG, Mallaber LM, Myers TW, Bambara RA, Fay PJ. Polymerization and RNase H activities of the reverse transcriptases from avian myeloblastosis, human immunodeficiency, and Moloney murine leukemia viruses are functionally uncoupled. J Biol Chem 1991; 266(12): 7423-31.
[http://dx.doi.org/10.1016/S0021-9258(20)89464-2] [PMID: 1708386]
[4]
Oscorbin IP, Wong PF, Boyarskikh UA, Khrapov EA, Filipenko ML. The attachment of a DNA-binding Sso7d-like protein improves processivity and resistance to inhibitors of M-MuLV reverse transcriptase. FEBS Lett 2020; 594(24): 4338-56.
[http://dx.doi.org/10.1002/1873-3468.13934] [PMID: 32970841]
[5]
Zhang YJ, Pan HY, Gao SJ. Reverse transcription slippage over the mRNA secondary structure of the LIP1 gene. Biotechniques 2001; 31(6): 1286-94.
[http://dx.doi.org/10.2144/01316st02] [PMID: 11768657]
[6]
Yasukawa K, Mizuno M, Konishi A, Inouye K. Increase in thermal stability of Moloney Murine leukaemia virus reverse transcriptase by site-directed mutagenesis. J Biotechnol 2010; 150(3): 299-306.
[http://dx.doi.org/10.1016/j.jbiotec.2010.09.961] [PMID: 20933548]
[7]
Baba M, Kakue R, Leucht C, et al. Further increase in thermostability of Moloney Murine leukemia virus reverse transcriptase by mutational combination. Protein Eng Des Sel 2017; 30(8): 551-7.
[http://dx.doi.org/10.1093/protein/gzx046] [PMID: 28967961]
[8]
Katano Y, Li T, Baba M, et al. Generation of thermostable Moloney Murine leukemia virus reverse transcriptase variants using site saturation mutagenesis library and cell-free protein expression system. Biosci Biotechnol Biochem 2017; 81(12): 2339-45.
[http://dx.doi.org/10.1080/09168451.2017.1394790] [PMID: 29103348]
[9]
Wang Y, Prosen DE, Mei L, Sullivan JC, Finney M, Vander Horn PB. A novel strategy to engineer DNA polymerases for enhanced processivity and improved performance in vitro. Nucleic Acids Res 2004; 32(3): 1197-207.
[http://dx.doi.org/10.1093/nar/gkh271] [PMID: 14973201]
[10]
Kalichuk V, Béhar G, Renodon-Cornière A, et al. The archaeal “7 kDa DNA-binding” proteins: Extended characterization of an old gifted family. Sci Rep 2016; 6(1): 37274.
[http://dx.doi.org/10.1038/srep37274] [PMID: 27853299]
[11]
Olszewski M. Śpibida M, Bilek M, Krawczyk B. Fusion of Taq DNA polymerase with single-stranded DNA binding-like protein of Nanoarchaeum equitans-Expression and characterization PLoS One 2017; 12(9): e0184162.
[http://dx.doi.org/10.1371/journal.pone.0184162] [PMID: 28863186]
[12]
Chen X, Zaro JL, Shen WC. Fusion protein linkers: Property, design and functionality. Adv Drug Deliv Rev 2013; 65(10): 1357-69.
[http://dx.doi.org/10.1016/j.addr.2012.09.039] [PMID: 23026637]
[13]
Arezi B, Hogrefe H. Novel mutations in Moloney Murine leukemia virus reverse transcriptase increase thermostability through tighter binding to template-primer. Nucleic Acids Res 2009; 37(2): 473-81.
[http://dx.doi.org/10.1093/nar/gkn952] [PMID: 19056821]
[14]
Yang J, Anishchenko I, Park H, Peng Z, Ovchinnikov S, Baker D. Improved protein structure prediction using predicted interresidue orientations. Proc Natl Acad Sci 2020; 117(3): 1496-503.
[http://dx.doi.org/10.1073/pnas.1914677117] [PMID: 31896580]
[15]
Heo L, Park H, Seok C. GalaxyRefine: Protein structure refinement driven by side-chain repacking. Nucleic Acids Res 2013; 41(W1): W384-8.
[http://dx.doi.org/10.1093/nar/gkt458] [PMID: 23737448]
[16]
Wiederstein M, Sippl MJ. ProSA-web: Interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res 2007; 35 (Suppl. 2): W407-10.
[http://dx.doi.org/10.1093/nar/gkm290] [PMID: 17517781]
[17]
Davis IW, Leaver-Fay A, Chen VB, et al. MolProbity: All-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res 2007; 35 (Suppl. 2): W375-83.
[http://dx.doi.org/10.1093/nar/gkm216] [PMID: 17452350]
[18]
Colovos C, Yeates TO. Verification of protein structures: Patterns of nonbonded atomic interactions. Protein Sci 1993; 2(9): 1511-9.
[http://dx.doi.org/10.1002/pro.5560020916] [PMID: 8401235]
[19]
Schymkowitz J, Borg J, Stricher F, Nys R, Rousseau F, Serrano L. The FoldX web server: An online force field. Nucleic Acids Res 2005; 33 (Suppl. 2): W382-8.
[http://dx.doi.org/10.1093/nar/gki387] [PMID: 15980494]
[20]
van Zundert GCP, Rodrigues JPGLM, Trellet M, et al. The HADDOCK2. 2 web server: User-friendly integrative modeling of biomolecular complexes. J Mol Biol 2016; 428(4): 720-5.
[http://dx.doi.org/10.1016/j.jmb.2015.09.014] [PMID: 26410586]
[21]
Laskowski RA, Swindells MB. LigPlot+: Multiple ligand-protein interaction diagrams for drug discovery. J Chem Inf Model 2011; 51(10): 2778-86.
[http://dx.doi.org/10.1021/ci200227u] [PMID: 21919503]
[22]
Yang W, Deng L. PreDBA: A heterogeneous ensemble approach for predicting protein-DNA binding affinity. Sci Rep 2020; 10(1): 1-1.
[PMID: 31913322]
[23]
Gasteiger E, Gattiker A, Hoogland C, Ivanyi I, Appel RD, Bairoch A. ExPASy: The proteomics server for in-depth protein knowledge and analysis. Nucleic Acids Res 2003; 31(13): 3784-8.
[http://dx.doi.org/10.1093/nar/gkg563] [PMID: 12824418]
[24]
Grote A, Hiller K, Scheer M, et al. JCat: A novel tool to adapt codon usage of a target gene to its potential expression host. Nucleic Acids Res 2005; 33 (Suppl. 2): W526-.
[http://dx.doi.org/10.1093/nar/gki376] [PMID: 15980527]
[25]
GenScript GenScript Rare Codon Analysis Tool. 2002. Available from :https://www.genscript.com/tools/rare-codonanalysis
[26]
Messaoudi A, Belguith H, Ben HJ. Homology modeling and virtual screening approaches to identify potent inhibitors of VEB-1 β-lactamase. Theor Biol Med Model 2013; 10(1): 22.
[http://dx.doi.org/10.1186/1742-4682-10-22] [PMID: 23547944]
[27]
Das D, Georgiadis MM. The crystal structure of the monomeric reverse transcriptase from Moloney Murine leukemia virus. Structure 2004; 12(5): 819-29.
[http://dx.doi.org/10.1016/j.str.2004.02.032] [PMID: 15130474]
[28]
Lengauer T, Rarey M. Computational methods for biomolecular docking. Curr Opin Struct Biol 1996; 6(3): 402-6.
[http://dx.doi.org/10.1016/S0959-440X(96)80061-3] [PMID: 8804827]
[29]
Sørensen H, Mortensen K. Soluble expression of recombinant proteins in the cytoplasm of Escherichia coli. Microb Cell Fact 2005; 4(1): 1-8.
[http://dx.doi.org/10.1186/1475-2859-4-1] [PMID: 15629064]
[30]
Bhatwa A, Wang W, Hassan YI, Abraham N, Li XZ, Zhou T. Challenges associated with the formation of recombinant protein inclusion bodies in Escherichia coli and strategies to address them for industrial applications. Front Bioeng Biotechnol 2021; 9: 630551.
[http://dx.doi.org/10.3389/fbioe.2021.630551] [PMID: 33644021]
[31]
Parsy CB, Chapman CJ, Barnes AC, Robertson JF, Murray A. Two-step method to isolate target recombinant protein from co-purified bacterial contaminant SlyD after immobilised metal affinity chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 2007; 853(1-2): 314-9.
[http://dx.doi.org/10.1016/j.jchromb.2007.03.046] [PMID: 17459787]
[32]
Wang Y. Improved Nucleic Acid Modifying Enzymes International Patent WO 01/92501 A1, 2001.

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy